|
Biotech News International news Biotechnology news from around the world. |
- Chiron submits preliminary dossier for potential pandemic flu vaccine to European Medicines Agency
- Call for network of biotechnology leaders to prevent biotechnology misuse
Chiron submits preliminary dossier for potential pandemic flu vaccine to European Medicines Agency
24 February – Chiron Corporation has submitted a preliminary dossier to the European Medicines Agency for a potential human pandemic bird flu vaccine. Chiron is the second company (following GlaxoSmithKline) to use the 'core dossier' approach which allows the evaluation and approval of an application based on a 'mock-up vaccine' before the outbreak of a pandemic. Once the actual virus strain has been identified at the time of the outbreak of the influenza pandemic, a variation to the core dossier is submitted to incorporate that strain. Chiron announced that it has entered into a supply contract with the UK government for pre-pandemic influenza vaccine for a stockpile based on the H5N1 avian influenza virus strain.
[Sources: European Medicines Agency; Company announcement]
Call for network of biotechnology leaders to prevent biotechnology misuse
February – Members of the Toronto based Joint centre for Bioethics call on the world leaders, at the July 2006 G8 meeting, to establish a global network with the aim of resolving potential conflicts between bioterrorism control and biotechnology development. The report on biodevelopment and biosecurity states that promoting the good use of biotechnology will help fight bioterrorism by building a global network of experts who can identify attempts to misuse the science.
[Source: University of Toronto, Joint Centre for Bioethics]
